Pharma Giant GlaxoSmithKline Signs Mega Deal With Pfizer That Could Change the Face of Global Healthcare
Read Full Article
- British pharmaceuticals giant GlaxoSmithKline will combine its consumer health business into a joint venture with US rival Pfizer to create a medical superpower.
- The deal could forge the largest provider of medicinal products sold directly to the public in the world.
- The move means that GSK will split into two businesses going forward.
Two of the world's largest pharmaceuticals companies are set to merge in a joint venture which could have combined sales of nearly $10 billion...